Wasatch Advisors LP Buys 186,357 Shares of OrthoPediatrics Corp. $KIDS

Key Points

• Wasatch Advisors increased its OrthoPediatrics stake by 56.6% in the second quarter, purchasing 186,357 additional shares and bringing its holdings to 515,677 shares, or 2.01% of the company. Institutional investors collectively own 69.05% of KIDS.
• OrthoPediatrics reported a quarterly loss of $0.26 per share, beating estimates of a $0.30 loss, while revenue of $70.51 million exceeded expectations of $68.21 million. The company remains unprofitable, with a negative net margin of 15.72%.
• KIDS shares recently traded at $24.86, near their 52-week high, while analysts maintain a “Moderate Buy” consensus rating and an average price target of $25.89.

Wasatch Advisors LP increased its stake in OrthoPediatrics Corp. (NASDAQ:KIDS - Free Report) by 56.6% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 515,677 shares of the company's stock after buying an additional 186,357 shares during the period. Wasatch Advisors LP owned 2.01% of OrthoPediatrics worth $9,865,000 as of its most recent SEC filing.

A number of other hedge funds have also added to or reduced their stakes in KIDS. Russell Investments Group Ltd. increased its holdings in OrthoPediatrics by 433.1% during the 3rd quarter. Russell Investments Group Ltd. now owns 1,402 shares of the company's stock worth $26,000 after purchasing an additional 1,139 shares during the period. Northwestern Mutual Wealth Management Co. raised its position in OrthoPediatrics by 5,226.5% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 2,610 shares of the company's stock valued at $46,000 after purchasing an additional 2,561 shares in the last quarter. Caption Management LLC purchased a new stake in shares of OrthoPediatrics in the 3rd quarter worth $54,000. BNP Paribas Financial Markets lifted its holdings in shares of OrthoPediatrics by 60.2% in the 3rd quarter. BNP Paribas Financial Markets now owns 3,288 shares of the company's stock worth $61,000 after buying an additional 1,235 shares during the period. Finally, State of Wyoming grew its position in shares of OrthoPediatrics by 189.7% during the 4th quarter. State of Wyoming now owns 6,822 shares of the company's stock worth $121,000 after buying an additional 4,467 shares in the last quarter. 69.05% of the stock is currently owned by institutional investors.

OrthoPediatrics Trading Up 2.6%

Shares of NASDAQ KIDS opened at $24.86 on Thursday. OrthoPediatrics Corp. has a 1-year low of $14.42 and a 1-year high of $25.01. The business has a fifty day moving average price of $19.83 and a 200 day moving average price of $18.02. The stock has a market capitalization of $649.09 million, a P/E ratio of -14.80 and a beta of 0.98. The company has a debt-to-equity ratio of 0.28, a current ratio of 4.78 and a quick ratio of 2.17.

OrthoPediatrics (NASDAQ:KIDS - Get Free Report) last posted its earnings results on Tuesday, August 4th. The company reported ($0.26) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.30) by $0.04. The company had revenue of $70.51 million for the quarter, compared to analyst estimates of $68.21 million. OrthoPediatrics had a negative return on equity of 8.10% and a negative net margin of 15.72%. Equities research analysts expect that OrthoPediatrics Corp. will post -1.14 EPS for the current fiscal year.

Analyst Ratings Changes

KIDS has been the topic of several research reports. TD Cowen restated a "buy" rating on shares of OrthoPediatrics in a research note on Monday, June 15th. Weiss Ratings upgraded shares of OrthoPediatrics from a "sell (e+)" rating to a "sell (d-)" rating in a report on Wednesday, August 5th. BTIG Research reiterated a "buy" rating and set a $24.00 target price on shares of OrthoPediatrics in a report on Friday, May 1st. Piper Sandler reissued an "overweight" rating and set a $25.00 target price (up from $22.00) on shares of OrthoPediatrics in a research report on Wednesday, August 5th. Finally, Canaccord Genuity Group set a $25.00 price objective on shares of OrthoPediatrics in a research note on Friday, April 24th. Nine investment analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, OrthoPediatrics presently has an average rating of "Moderate Buy" and an average price target of $25.89.

OrthoPediatrics Company Profile

OrthoPediatrics Corp., founded in 2007 and headquartered in Warsaw, Indiana, is a medical device company dedicated exclusively to providing orthopedic solutions for children. The company focuses on developing, manufacturing and marketing a broad portfolio of implants and instruments designed to address a wide range of pediatric conditions, including trauma, deformity correction, spine disorders and sports injuries.

The company's product lines include locking plates and screws for upper and lower extremity reconstruction, intramedullary nails for femur and tibia stabilization, and specialized systems such as the MAGEC Magnetic Growth Rod for treatment of early-onset scoliosis.

Want to see what other hedge funds are holding KIDS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for OrthoPediatrics Corp. (NASDAQ:KIDS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source